Finance

IKS Health Unveils AI-Driven Healthcare Workflow Platform
Technology IKS Health Unveils AI-Driven Healthcare Workflow Platform

In an era where healthcare inefficiencies burden clinicians and impact patient care, imagine a system that seamlessly connects every step of the patient journey—from scheduling an appointment to final reimbursement. This vision became a reality at the Vitalize Health Summit, held from September 4-7

Hinge Health's Stellar Growth Amid Q2 2025 Challenges
Data and Information Hinge Health's Stellar Growth Amid Q2 2025 Challenges

Setting the Stage: A Digital Health Revolution in Motion In an era where healthcare costs are soaring and chronic conditions burden millions, digital health platforms are emerging as game-changers, transforming how care is delivered and managed. Hinge Health (NYSE: HNGE), a leader in chronic

What’s Driving Healthcare Mergers Like UHG and Walgreens?
Business What’s Driving Healthcare Mergers Like UHG and Walgreens?

Imagine a healthcare landscape where giants like UnitedHealth Group (UHG) and Walgreens are reshaping the very foundation of care delivery through billion-dollar mergers, setting a new standard for the industry. With UHG’s $3.3 billion acquisition of Amedisys and Sycamore Partners’ staggering $10 bi

Why Is Michigan's Medicaid Work Requirement a Warning?
Business Why Is Michigan's Medicaid Work Requirement a Warning?

In the realm of public health policy, few have navigated the complexities of Medicaid regulations as adeptly as Robert Gordon, former Michigan state health director. During his tenure, Gordon spearheaded the implementation of a controversial Medicaid work requirement, a policy he inherited under a

Is GE HealthCare a Buy Despite Mixed Market Signals?
Business Is GE HealthCare a Buy Despite Mixed Market Signals?

Unraveling the Complexities of GE HealthCare’s Market Position In the dynamic realm of healthcare investments, GE HealthCare (GEHC) emerges as a fascinating case study, capturing attention with its robust financial health while grappling with troubling market signals. Imagine a company with a solid

Insurers Cut GLP-1 Drug Costs by Weaning Patients Off
Business Insurers Cut GLP-1 Drug Costs by Weaning Patients Off

What happens when a life-altering medication becomes a financial burden too heavy for healthcare systems to bear? GLP-1 drugs, such as Ozempic and Wegovy, have transformed the lives of millions struggling with obesity and Type 2 diabetes, offering hope where traditional methods often failed. Yet,

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later